Spinocerebellar Ataxia Type 2
Neurology·MeSH: Spinocerebellar Ataxias
Prevalence
5.0 / 100K
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Frequently asked questions
How many drugs are in development for Spinocerebellar Ataxia Type 2?
BioSniper tracks 2 drugs in development for Spinocerebellar Ataxia Type 2 across 1 company.
How many clinical trials target Spinocerebellar Ataxia Type 2?
There are 3 clinical trials targeting Spinocerebellar Ataxia Type 2 tracked by BioSniper.
What is the prevalence of Spinocerebellar Ataxia Type 2?
The estimated prevalence of Spinocerebellar Ataxia Type 2 is approximately 5.0 per 100,000 population.
Deep-dive into Spinocerebellar Ataxia Type 2
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis